Weiss Ratings Reiterates "Hold (C-)" Rating for Nutex Health (NASDAQ:NUTX)

Key Points

• Weiss Ratings has reiterated a "hold (C-)" rating for Nutex Health (NASDAQ:NUTX), indicating a cautious stance on the stock's performance.
• Maxim Group set a target price of $205.00 and assigned a "buy" rating, while Wall Street Zen upgraded it to a "strong-buy," contributing to a consensus rating of "Moderate Buy" with an average price target of $252.50.
• Nutex Health has seen significant investments from institutional investors, including a 6,590.3% increase in position by Bank of America Corp DE, showcasing growing interest in the company's stock.

Nutex Health (NASDAQ:NUTX - Get Free Report)'s stock had its "hold (c-)" rating reiterated by Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

Other equities research analysts have also recently issued research reports about the stock. Maxim Group set a $205.00 target price on shares of Nutex Health and gave the stock a "buy" rating in a research note on Tuesday, August 26th. Wall Street Zen upgraded shares of Nutex Health from a "hold" rating to a "strong-buy" rating in a research note on Friday, September 26th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $252.50.

Nutex Health Price Performance

NASDAQ NUTX opened at $102.74 on Wednesday. Nutex Health has a 12 month low of $17.66 and a 12 month high of $184.27. The stock has a market cap of $570.72 million, a price-to-earnings ratio of 8.64 and a beta of -0.20. The company's 50 day moving average is $93.88 and its two-hundred day moving average is $110.84. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02.

Institutional Investors Weigh In On Nutex Health

Several large investors have recently bought and sold shares of NUTX. Bank of America Corp DE increased its position in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after purchasing an additional 2,043 shares during the last quarter. Millennium Management LLC bought a new stake in Nutex Health in the fourth quarter worth $213,000. Baader Bank Aktiengesellschaft increased its position in Nutex Health by 64.6% in the first quarter. Baader Bank Aktiengesellschaft now owns 10,700 shares of the company's stock worth $503,000 after purchasing an additional 4,200 shares during the last quarter. Informed Momentum Co LLC bought a new stake in Nutex Health in the first quarter worth $868,000. Finally, American Century Companies Inc. increased its position in Nutex Health by 73.0% in the first quarter. American Century Companies Inc. now owns 74,359 shares of the company's stock worth $3,497,000 after purchasing an additional 31,366 shares during the last quarter. Institutional investors own 5.32% of the company's stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.